Oxidative stress and the etiology of insulin resistance and type 2 diabetes

Free Radical Biology and Medicine

Volumn 51, Issue 5, 2011, Pages 993-999

  Henriksen, Erik J ^a   Diamond Stanic, Maggie K ^a   Marchionne, Elizabeth M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Free radicals; Glucose transport; Hydrogen peroxide; Lipoic acid; Obese Zucker rat; Skeletal muscle

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANTIOXIDANT; APOCYNIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE OXIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRIDOXAMINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TEMPOL; THIOCTIC ACID; WORTMANNIN;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE MODEL; DRUG EFFICACY; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; EXERCISE; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT SYSTEM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN BINDING; INSULIN RESISTANCE; INSULIN SENSITIVITY; NEGATIVE FEEDBACK; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SKELETAL MUSCLE; TREATMENT DURATION;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HUMANS; HYDROGEN PEROXIDE; INSULIN RESISTANCE; MUSCLE, SKELETAL; NADPH OXIDASE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDES;

ANIMALIA; MAMMALIA; RATTUS;

EID: 80051669138     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.12.005     Document Type: Review

References (92)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diab. Care 33 2010 S62 S69
2. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health: National diabetes statistics Reference available from http://diabetes.niddk.nih.gov/dm/pubs/statistics/#3 accessed on 18 August 2010
3. E.J. Henriksen Dysregulation of glycogen synthase kinase-3 and the etiology of insulin resistance and type 2 diabetes Curr. Diab. Rev. 6 2010 285 293
4. R.A. DeFronzo, E. Ferrannini, R. Hendler, P. Felig, and J. Wahren Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man Diabetes 32 1983 32 45
5. A.D. Baron, G. Brechtel, P. Wallace, and S.V. Edelman Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans Am. J. Physiol. Endocrinol. Metab. 255 1988 E769 E774
6. P.R. Shepherd, and B.B. Kahn Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus N. Engl. J. Med. 341 1999 248 257 (Pubitemid 29334524)
7. J.R. Zierath, A. Krook, and H. Wallberg-Henriksson Insulin action and insulin resistance in human skeletal muscle Diabetologia 43 2000 821 835 (Pubitemid 30463160)
8. E.J. Henriksen Effects of acute exercise and exercise training on insulin resistance J. Appl. Physiol. 93 2002 788 796 (Pubitemid 34810247)
9. G.D. Cartee, and J.F. Wojtaszewski Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport Appl. Physiol. Nutr. Metab. 32 2007 557 566
10. T. Ikenoue, K. Inoki, Q. Yang, X. Zhou, and K.L. Guan Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signaling EMBO J. 27 2008 1919 1931
11. E. Kleiman, G. Carter, T. Ghansah, N.A. Patel, and D.R. Cooper Developmentally spliced PKCβII provides a possible link between mTORC2 and Akt kinase to regulate 3T3-L1 adipocyte insulin-stimulated glucose transport Biochem. Biophys. Res. Commun. 388 2009 554 559
12. H. Sano, S. Kane, E. Sano, C.P. Miinea, J.M. Asara, W.S. Lane, C.W. Garner, and G.E. Lienhard Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation J. Biol. Chem. 278 2003 14599 14602 (Pubitemid 36799780)
13. C.M. Taniguchi, B. Brice Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96 (Pubitemid 43278292)
14. E.J. Henriksen Oxidative stress and antioxidant treatment: effects on muscle glucose transport in animal models of type 1 and type 2 diabetes L. Packer, P. Rösen, H.J. Tritschler, G.L. King, A. Azzi, Antioxidants in Diabetes Management 2000 Dekker New York 303 318
15. E.J. Henriksen Therapeutic effects of lipoic acid on hyperglycemia and insulin resistance E. Cadenas, L. Packer, Handbook of Antioxidants 2001 Dekker New York 535 548
16. J.L. Evans, I.D. Goldfine, B.A. Maddux, and G.M. Grodsky Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr. Rev. 23 2002 599 622 (Pubitemid 35191625)
17. J.L. Evans, I.D. Goldfine, B.A. Maddux, and G.M. Grodsky Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52 2003 1 8 (Pubitemid 36042100)
18. E.J. Henriksen Exercise training and the antioxidant α-lipoic acid in the treatment of insulin resistance and type 2 diabetes Free Radic. Biol. Med. 40 2006 3 12 (Pubitemid 41759398)
19. G. Paolisso, A. D'Amore, C. Volpe, V. Balbi, F. Saccomanno, D. Galzerano, D. Giugliano, M. Varricchio, and F. D'Onofrio Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients Metabolism 43 1994 1426 1429 (Pubitemid 24353109)
20. J. Nourooz-Zadeh, A. Rahimi, J. Tajaddini-Sarmadi, H. Tritschler, P. Rösen, B. Halliwell, and D.J. Betteridge Relationships between plasma measures of oxidative stress and metabolic control in NIDDM Diabetologia 40 1997 647 653 (Pubitemid 27288109)
21. G. Solinas, and M. Karin JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction FASEB J. 24 2010 2596 2611
22. V. Saengsirisuwan, T.R. Kinnick, M.B. Schmit, and E.J. Henriksen Interactions of exercise training and lipoic acid on skeletal muscle glucose transport in obese Zucker rats J. Appl. Physiol. 91 2001 145 153 (Pubitemid 32577084)
23. M. Kaneki, N. Shimizu, D. Yamada, and K. Chang Nitrosative stress and pathogenesis of insulin resistance Antioxid. Redox Signaling 9 2007 319 329 (Pubitemid 46145980)
24. P.A. Grimsrud, H. Xie, T.J. Griffin, and D.A. Bernlohr Oxidative stress and covalent modification of protein with bioactive aldehydes J. Biol. Chem. 283 2008 21837 21841
25. E.A. Muellenbach, C.J. Diehl, M.K. Teachey, K.A. Lindborg, T.L. Archuleta, N.B. Harrell, O. Hasselwander, G. Andersen, V. Somoza, M. Matuschek, and E.J. Henriksen Interactions of the AGE inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance of the obese Zucker rat Metabolism 57 2008 1465 1472
26. E.A. Muellenbach, C.J. Diehl, M.K. Teachey, K.A. Lindborg, O. Hasselwander, M. Matuschek, and E.J. Henriksen Metabolic interactions of the AGE inhibitor pyridoxamine and the antioxidant alpha-lipoic acid following 22 weeks of treatment in obese Zucker rats Life Sci. 84 2009 563 568
27. J.R. Stone, and S. Yang Hydrogen peroxide: a signaling messenger Antioxid. Redox Signaling 8 2006 243 270 (Pubitemid 43741296)
28. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans J. Clin. Invest. 119 2009 573 581
29. G.J. Dietze, and E.J. Henriksen Angiotensin I-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis J. Renin-Angiotensin-Aldosterone Syst. 9 2008 75 88 (Pubitemid 351998215)
30. E.J. Henriksen Improvement of insulin sensitivity by antagonism of the renin-angiotensin system Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 2007 R974 R980
31. D. Javesghani, S.A. Magder, E. Barreiro, M.T. Quinn, and S.N. Hussain Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles Am. J. Respir. Crit. Care Med. 165 2002 412 418 (Pubitemid 34118518)
32. Y. Wei, J.R. Sowers, R. Nistala, H. Gong, G.M. Uptergrove, S.E. Clark, E.M. Morris, N. Szary, C. Manrique, and C.S. Stump Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells J. Biol. Chem. 281 2006 35137 35146 (Pubitemid 46036553)
33. J.R. Sowers Insulin resistance and hypertension Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1597 H1602
34. A. Rudich, N. Kozlovsky, R. Potashnik, and N. Bashan Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes Am. J. Physiol. Endocrinol. Metab. 272 1997 E935 E940
35. A. Rudich, A. Tirosh, R. Potashnik, R. Hemi, H. Kanety, and N. Bashan Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes Diabetes 47 1998 1562 1569 (Pubitemid 28445343)
36. B.A. Maddux, W. See, J.C. Lawrence Jr., A.L. Goldfine, I.D. Goldfine, and J.L. Evans Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid Diabetes 50 2001 404 410 (Pubitemid 32127299)
37. E.J. Henriksen, and J.O. Holloszy Effect of diffusion distance on measurement of glucose transport in rat skeletal muscles in vitro Acta Physiol. Scand. 143 1991 381 386
38. J.S. Kim, V. Saengsirisuwan, J.A. Sloniger, M.K. Teachey, and E.J. Henriksen Oxidant stress and skeletal muscle glucose transport: roles of insulin signaling and p38 MAPK Free Radic. Biol. Med. 41 2006 818 824 (Pubitemid 44163415)
39. B.B. Dokken, V. Saengsirisuwan, J.S. Kim, M.K. Teachey, and E.J. Henriksen Oxidative stress-induced insulin resistance in skeletal muscle: role of glycogen synthase kinase-3 Am. J. Physiol. Endocrinol. Metab. 294 2008 E615 E621
40. T.L. Archuleta, A.M. Lemieux, V. Saengsirisuwan, M.K. Teachey, K.A. Lindborg, J.S. Kim, and E.J. Henriksen Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK Free Radic. Biol. Med. 47 2009 1486 1493
41. R. Potashnik, A. Bloch-Damti, and N. Bashan IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress Diabetologia 46 2003 639 648 (Pubitemid 36808184)
42. A.S. Blair, E. Hajduch, G.J. Litherland, and H.S. Hundal Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways J. Biol. Chem. 274 1999 36293 36299
43. M.K. Diamond-Stanic, E.M. Marchionne, D.E. Durazo, E.J. Schoolmaster, M.K. Teachey, J.S. Kim, and E.J. Henriksen Critical role of transient activation of p38 MAPK in the etiology of skeletal muscle insulin resistance caused by low-level in vitro oxidant stress Diabetes 59 Suppl. 1 2010 A368
44. K. Vichaiwong, E.J. Henriksen, C. Toskulkao, M. Prasannarong, T. Bupha-Intr, and V. Saengsirisuwan Attenuation of oxidant-induced muscle insulin resistance and p38 MAPK by exercise training Free Radic. Biol. Med. 47 2009 593 599
45. J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, K. Maeda, M. Karin, and G.S. Hotamisligil A central role for JNK in obesity and insulin resistance Nature 420 2002 333 336 (Pubitemid 35398190)
46. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, and S.E. Shoelson Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 2001 1673 1677 (Pubitemid 32807849)
47. T. Ogihara, T. Asano, K. Ando, Y. Chiba, H. Sakoda, M. Anai, N. Shojima, H. Ono, Y. Onishi, M. Fujishiro, K. Katagiri, Y. Fukushima, M. Kikuchi, N. Noguchi, H. Aburatani, I. Komuro, and T. Fujita Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling Hypertension 40 2002 872 879 (Pubitemid 35434909)
48. M.C. Blendea, D. Jacobs, C.S. Stump, S.I. McFarlane, C. Ogrin, G. Bahtyiar, S. Stas, P. Kumar, Q. Sha, C.M. Ferrario, and J.R. Sowers Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am. J. Physiol. Endocrinol. Metab. 288 2005 E353 E359
49. J.A. Sloniger, V. Saengsirisuwan, C.J. Diehl, B.B. Dokken, N. Lailerd, A.M. Lemieux, J.S. Kim, and E.J. Henriksen Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat Am. J. Physiol. Endocrinol. Metab. 288 2005 E1074 E1081
50. J.A. Sloniger, V. Saengsirisuwan, C.J. Diehl, J.S. Kim, and E.J. Henriksen Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats Metabolism 54 2005 1659 1668 (Pubitemid 41728160)
51. Y. Wei, J.R. Sowers, S.E. Clark, W. Li, C.M. Ferrario, and C.S. Stump Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kB activation via NADPH oxidase Am. J. Physiol. Endocrinol. Metab. 294 2008 E345 E351
52. E.J. Henriksen, and S. Jacob Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats Metabolism 44 1995 267 272
53. E.J. Henriksen, S. Jacob, T.R. Kinnick, M.K. Teachey, and M. Krekler Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats Hypertension 38 2001 884 890 (Pubitemid 34258687)
54. M.K. Diamond-Stanic, and E.J. Henriksen Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism Arch. Physiol. Biochem. 116 2010 88 95
55. L. Packer, E.H. Witt, and H.J. Tritschler α-Lipoic acid as a biological antioxidant Free Radic. Biol. Med. 19 1995 227 250
56. L. Packer, K. Kraemer, and G. Rimbach Molecular aspects of lipoic acid in the prevention of diabetes complications Nutrition 17 2001 888 895 (Pubitemid 33001657)
57. D.E. Estrada, H.S. Ewart, T. Tsakiridis, A. Volchuk, T. Ramlal, H. Tritschler, and A. Klip Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway Diabetes 45 1996 1798 1804 (Pubitemid 26398962)
58. A. Rudich, A. Tirosh, R. Potashnik, M. Khamaisi, and N. Bashan Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes Diabetologia 42 1999 949 957 (Pubitemid 29369603)
59. K. Yaworsky, R. Somwar, T. Ramlal, H.J. Tritschler, and A. Klip Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes Diabetologia 43 2000 294 303 (Pubitemid 30163472)
60. D. Konrad, R. Somwar, G. Sweeney, K. Yaworsky, M. Hayashi, T. Ramlal, and A. Klip The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation Diabetes 50 2001 1464 1471 (Pubitemid 32500181)
61. E.J. Henriksen, S. Jacob, R.S. Streeper, D.L. Fogt, J.Y. Hokama, and H.J. Tritschler Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats Life Sci. 61 1997 805 812 (Pubitemid 27326936)
62. S. Jacob, R.S. Streeper, D.L. Fogt, J.Y. Hokama, H.J. Tritschler, G.J. Dietze, and E.J. Henriksen The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant skeletal muscle Diabetes 45 1996 1024 1029 (Pubitemid 26260153)
63. M. Khamaisi, R. Potashnik, A. Tirosh, E. Demshchak, A. Rudich, H. Tritschler, K. Wessel, and N. Bashan Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats Metabolism 46 1997 763 768 (Pubitemid 27300618)
64. R.S. Streeper, E.J. Henriksen, S. Jacob, J.Y. Hokama, D.L. Fogt, H.J. Tritschler, and G.J. Dietze Differential effects of stereoisomers of alpha-lipoic acid on glucose metabolism in insulin-resistant rat skeletal muscle Am. J. Physiol. Endocrinol. Metab. 273 1997 E185 E191
65. A. El Midaoui, and J. de Champlain Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid Hypertension 39 2002 303 307 (Pubitemid 34165233)
66. V. Saengsirisuwan, F.R. Perez, J.A. Sloniger, T. Maier, and E.J. Henriksen Interactions of exercise training and R-(+)-alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats Am. J. Physiol. Endocrinol. Metab. 287 2004 E529 E536
67. K.-H. Song, W.J. Lee, J.-M. Koh, H.S. Kim, J.-Y. Youn, H.-S. Park, E.H. Koh, M.-S. Kim, J.H. Youn, K.-U. Lee, and J.-Y. Park α-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats Biochem. Biophys. Res. Commun. 326 2004 197 202 (Pubitemid 39573219)
68. A.A. Gupte, G.L. Bomhoff, J.K. Morris, B.K. Gorres, and P.C. Geiger Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats J. Appl. Physiol. 106 2009 1425 1434
69. S. Jacob, E.J. Henriksen, A.L. Schiemann, I. Simon, D.E. Clancy, H.J. Tritschler, W.I. Jung, H.J. Augustin, and G.J. Dietze Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid Drug Res. 45 1995 872 874
70. S. Jacob, E.J. Henriksen, H.J. Tritschler, H.J. Augustin, and G.J. Dietze Improvement of insulin-stimulated glucose disposal in type 2 diabetes after repeated parenteral administration of thioctic acid Exp. Clin. Endocrinol. Diab. 104 1996 284 288 (Pubitemid 26225997)
71. S. Jacob, P. Ruus, R. Hermann, H.J. Tritschler, E. Maerker, W. Renn, H.J. Augustin, G.J. Dietze, and K. Rett Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type 2 diabetes mellitus-a placebo controlled pilot trial Free Radic. Biol. Med. 27 1999 309 314 (Pubitemid 29395422)
72. A. Cassese, I. Esposito, F. Fiory, A.P. Barbagallo, F. Paturzo, P. Mirra, L. Ulianich, F. Giacco, C. Iadicicco, A. Lombardi, F. Oriente, E. Van Obberghen, F. Beguinot, P. Formisano, and C. Miele In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs J. Biol. Chem. 283 2008 36088 36099
73. S.R. Thorpe, and J.W. Baynes Role of the Maillard reaction in diabetes mellitus and diseases of aging Drugs Ageing 9 1996 69 77 (Pubitemid 26261743)
74. P. Ulrich, and A. Cerami Protein glycation, diabetes, and aging Recent Prog. Horm. Res. 56 2001 1 21
75. T.O. Metz, N.L. Alderson, M.E. Chachich, S.R. Thorpe, and J.W. Baynes Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of proteins and development of diabetic complications J. Biol. Chem. 278 2003 42012 42019 (Pubitemid 37310465)
76. T.O. Metz, N.L. Alderson, S.R. Thorpe, and J.W. Baynes Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications Arch. Biochem. Biophys. 419 2003 41 49 (Pubitemid 37272158)
77. T.P. Degenhardt, N.L. Alderson, D.D. Arrington, R.J. Beattie, J.M. Basgen, M.W. Steffes, S.R. Thorpe, and J.W. Baynes Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney Int. 61 2002 939 950 (Pubitemid 34175462)
78. A. Stitt, T.A. Gardiner, N.L. Alderson, P. Canning, N. Frizzell, N. Duffy, C. Boyle, A.S. Januszewski, Chachich M., J.W. Baynes, and S.R. Thorpe The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2002 2826 2832 (Pubitemid 34970937)
79. N.L. Alderson, M.E. Chachich, N.N. Youssef, R.J. Beattie, M. Nachtigal, S.R. Thorpe, and J.W. Baynes The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats Kidney Int. 63 2003 2123 2133 (Pubitemid 36605823)
80. G. Orasanu, and J. Plutzky The continuum of diabetic vascular disease: from macro- to micro- J. Am. Coll. Cardiol. 53 2009 S35 S42
81. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820 (Pubitemid 34000785)
82. U.M. Steckelings, F. Rompe, E. Kaschina, and T. Unger The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets Fundam. Clin. Pharmacol. 23 2009 693 703
83. A.C. Maritim, R.A. Sanders, and J.B. Watkins III Diabetes, oxidative stress, and antioxidants: a review J. Biochem. Mol. Toxicol. 17 2003 24 38 (Pubitemid 36410972)
84. J.S. Johansen, A.K. Harris, D.J. Rychly, and A. Ergul Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice Cardiovasc. Diabetol. 4 2005 1 11
85. S. Boudina, and E.D. Able Diabetic cardiomyopathy, causes and effect Rev. Endocr. Metab. Disord. 11 2010 31 39
86. Z. Fatehi-Hassanabad, C.B. Chan, and B.L. Furman Reactive oxygen species and endothelial function in diabetes Eur. J. Pharmacol. 636 2010 8 17
87. K.M. Mellor, R.H. Ritchie, and L. Delbridge Reactive oxygen species and insulin-resistant cardiomyopathy Clin. Exp. Pharmacol. Physiol. 37 2010 222 228
88. J.M. Forbes, M.T. Coughlan, and M.E. Cooper Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
89. Y.S. Kanwar, J. Wada, L. Sun, P. Xie, E.I. Wallner, S. Chen, S. Chugh, and F.R. Danesh Diabetic nephropathy: mechanisms of renal disease progression Exp. Biol. Med. 233 2008 4 11
90. S.A. Madsen-Bouterse, and R.A. Kowluru Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives Rev. Endocr. Metab. Disord. 9 2008 315 327
91. C. Figueroa-Romero, M. Sadid, and E.L. Feldman Mechanisms of disease: the oxidative stress theory of diabetic neuropathy Rev. Endocr. Metab. Disord. 9 2008 301 314
92. R. Pazdro, and J.R. Burgess The role of vitamin E and oxidative stress in diabetes complications Mech. Ageing Dev. 131 2010 276 286